Mutant huntingtin represses CBP, but not p300, by binding and protein degradation
Mutant huntingtin represses CBP, but not p300, by binding and protein degradation
复制标题
DOI:
10.1016/j.mcn.2005.10.015
复制
发表时间:
2005-12-01
影响因子:
3.5
通讯作者:
Dorsman, JC
中科院分区:
文献类型:
--
作者:
Cong, SY;Pepers, BA;Dorsman, JC
Huntington's disease can be used as a model to study neurodegenerative disorders caused by aggregation-prone proteins. It has been proposed that the entrapment of transcription factors in aggregates plays an important role in pathogenesis. We now report that the transcriptional activity of CBP is already repressed in the early time points by soluble mutant huntingtin, whereas the histone acetylase activity of CBP/p300 is gradually diminished over time. Mutant huntingtin bound much stronger to CBP than normal huntingtin, possibly contributing to repression. Especially at the later time points, CBP protein level was gradually reduced via the proteasome pathway. In sharp contrast, p300 was unaffected by mutant huntingtin. This selective degradation of CBP was absent in spinocerebellar ataxia 3. Thus, mutant huntingtin specifically affects CBP and not p300 both at the early and later time points, via multiple mechanisms. In addition to the reduction of CBP, also the altered ratio of these closely related histone acetyltransferases may affect chromatin structure and transcription and thus contribute to neurodegeneration. (c) 2005 Elsevier Inc. All rights reserved.